MetaCap

Celularity Statistics

NASDAQ: CELUHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.44-0.032 (-2.18%)

Market open · Delayed 15 min · as of Oct 8, 10:29 AM ET

Celularity by the numbers

Celularity has a market capitalization of $46.7 million based on 32.45M shares outstanding. With trailing EPS of $-2.73, Celularity is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.1% above its 50-day average and 31.0% above its 200-day average.

Average daily trading volume is 3.89M shares, or about $5.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CELU valuation vs. peer median

CELU compared with the median of 8 peer companies
MetricCELUPeer medianDifference
Market cap$46.66M$48.74M-4%
Avg. volume3.89M346.45K+1023%

Peer median across 8 companies: CRVO, DWTX, ELTX, ANVS, SER, HOWL, NSRX, HYPD.

Valuation

Price and trading

Previous close
1.47
Open
1.46
Day range
1.44 – 1.49
52-week range
0.56 – 2.55
52-week change
-27.94%
Beta
—
Volume
11.83K

Dividends and events

Annual dividend
None
Next earnings date
Aug 18, 2025

Additional statistics

Market Cap
46.66M
Forward Pe
-2.52
Eps
-2.73
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.55
Week52 Low
0.56
Avg Volume
3.89M
Shares Outstanding
32.45M
Ma50
1.17
Ma200
1.10
Earnings Date
Aug 18, 2025
Pct From52w High
-43.61%
Pct From52w Low
156.79%

Related